Cyclo Therapeutics (CYTH) News Today $0.71 +0.03 (+4.42%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Cyclo Therapeutics (NASDAQ:CYTH) and Eloxx Pharmaceuticals (NASDAQ:ELOX) Head to Head ComparisonNovember 21 at 2:46 AM | americanbankingnews.comCyclo Therapeutics (NASDAQ:CYTH) Shares Up 3% - Should You Buy?November 19 at 2:33 AM | americanbankingnews.comCyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 15, 2024 | finance.yahoo.comPacira BioSciences Appoints Shawn Cross As CFOOctober 21, 2024 | markets.businessinsider.comMaxim Group Downgrades Cyclo Therapeutics (CYTH)August 29, 2024 | msn.comCYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTHAugust 27, 2024 | businesswire.comHC Wainwright & Co. Downgrades Cyclo Therapeutics (CYTH)August 24, 2024 | msn.comShareholder Alert: Ademi LLP investigates whether Cyclo Therapeutics, Inc. has obtained a Fair Price for its Public ShareholdersAugust 23, 2024 | prnewswire.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Cyclo Therapeutics, Inc. MergerAugust 22, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cyclo Therapeutics, Inc. - CYTHAugust 22, 2024 | prnewswire.comSector Update: Health Care Stocks Flat to Higher Premarket ThursdayAugust 22, 2024 | nasdaq.comRafael Holdings And Cyclo Therapeutics Agree To MergeAugust 22, 2024 | markets.businessinsider.comCyclo Therapeutics falls after merger agreement with Rafael HoldingsAugust 22, 2024 | msn.comCyclo Therapeutics Second Quarter 2024 Earnings: Misses ExpectationsAugust 18, 2024 | finance.yahoo.comOptimistic Buy Rating for Cyclo Therapeutics Amidst Promising Clinical Trials and Financial ProspectsAugust 17, 2024 | markets.businessinsider.comCyclo Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 15, 2024 | finance.yahoo.comCyclo Therapeutics Inc (CYTH)July 31, 2024 | investing.comCyclo Therapeutics secures European patent for Alzheimer's treatmentJuly 31, 2024 | investing.comCyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024June 25, 2024 | businesswire.comCyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1May 30, 2024 | businesswire.comCYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q1 2024May 16, 2024 | investorplace.comCyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 16, 2024 | businesswire.comHC Wainwright & Co. Initiates Coverage of Cyclo Therapeutics (CYTH) with Buy RecommendationMay 2, 2024 | msn.comAscendiant Capital Initiates Coverage of Cyclo Therapeutics (CYTH) with Buy RecommendationApril 23, 2024 | nasdaq.comAnalysts Offer Insights on Healthcare Companies: Cyclo Therapeutics (CYTH), CytomX Therapeutics (CTMX) and Pacific Biosciences (PACB)April 22, 2024 | markets.businessinsider.comPleasing Signs As A Number Of Insiders Buy Cyclo Therapeutics StockApril 10, 2024 | finance.yahoo.comCYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023March 19, 2024 | investorplace.comCyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateMarch 18, 2024 | businesswire.comCyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s DiseaseMarch 14, 2024 | finance.yahoo.comCyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer's DiseaseMarch 14, 2024 | businesswire.comCyclo Therapeutics, Inc. (CYTH)February 2, 2024 | finance.yahoo.comCyclo Therapeutics Gets Notice Of Allowance For Patent Regarding Treatment Of Alzheimer's DiseaseJanuary 29, 2024 | markets.businessinsider.comCyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark OfficeJanuary 29, 2024 | finance.yahoo.comCyclo Therapeutics Inc CYTHJanuary 3, 2024 | morningstar.comCytosorbents, Cyclo Therapeutics among healthcare moversDecember 28, 2023 | msn.comCyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1December 18, 2023 | finance.yahoo.comRafael Holdings Reports First Quarter Fiscal 2024 Financial ResultsDecember 14, 2023 | finance.yahoo.comAPPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied ...November 29, 2023 | businesswire.comCyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024November 21, 2023 | finance.yahoo.comCyclo Therapeutics reports Q3 resultsNovember 15, 2023 | msn.comCyclo Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 15, 2023 | finance.yahoo.comWISH, REAL and PIXY among mid-day moversNovember 10, 2023 | seekingalpha.comSeveral Insiders Invested In Cyclo Therapeutics Flagging Positive NewsNovember 2, 2023 | finance.yahoo.comRafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial ResultsOctober 30, 2023 | finance.yahoo.comCyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 MillionOctober 23, 2023 | finance.yahoo.comCyclo Therapeutics to Present at 8th Annual Dawson James ConferenceOctober 5, 2023 | finance.yahoo.comCYTH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cyclo Therapeutics, Inc. Is Fair to ShareholdersSeptember 21, 2023 | tmcnet.comCyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger AgreementSeptember 21, 2023 | finance.yahoo.comCyclo Therapeutics Reports Second Quarter 2023 Financial ResultsAugust 15, 2023 | finance.yahoo.comCyclo Therapeutics And This Other Penny Stock Insiders Are BuyingAugust 3, 2023 | benzinga.com Get Cyclo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTH and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. CYTH Media Mentions By Week CYTH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYTH News Sentiment▼-0.080.45▲Average Medical News Sentiment CYTH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYTH Articles This Week▼20▲CYTH Articles Average Week Get Cyclo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PMVP News QNCX News IMAB News CLSD News CMRX News FBLG News ME News ONCY News AVTE News EPIX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYTH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
